Posterior reversible encephalopathy syndrome (PRES) is a neuroradiologic syndrome. The etiology of PRES is still unclear. Some factors were described. We present a case of a pediatric patient with liver transplant who developed PRES following blood transfusion while receiving tacrolimus therapy. A 51/2-year-old boy who underwent living donor liver transplantation, and PRES developed on the sixth day post transplant under tacrolimus treatment after 6 hours of red blood transfusion. PRES is a rare condition; it should be kept in mind about patients who have received organ transplants and develop sudden neurologic symptoms
Reversible Posterior Encephalopathy Syndrome (PRES) is characterized by confusion, drowsiness, vomit...
Posterior reversible encephalopathy syndrome (PRES), also known as reversible posterior leukoencepha...
Posterior reversible encephalopathy syndrome (PRES) is a variable etiology clinical syndrome with si...
Posterior reversible encephalopathy syndrome (PRES), is a group of disorders which may present with ...
PRES is a neuroclinical and radiological syndrome that results from treatment with calcineurin inhib...
Posterior reversible encephalopathy syndrome (PRES) is a clinical neuroradiologic entity that is bec...
Since solid organ and hematopoietic stem cell transplantations have been performed increasingly rece...
Posterior reversible encephalopathy syndrome (PRES) is a clinico-neuroradiologic disease entity repr...
Tacrolimus is an immunosuppressive drug used to lower the risk of transplant rejection in individual...
Posterior reversible encephalopathy syndrome (PRES) is known to occur after solid organ transplantat...
<div><p>ABSTRACT Introduction: Posterior reversible leukoencephalopathy syndrome (PRES) was first d...
BACKGROUND AND PURPOSE: Posterior reversible encephalopathy syndrome (PRES) is known to occur after ...
BACKGROUND AND PURPOSE: Posterior reversible encephalopathy syndrome (PRES) is known to occur after ...
PubMedID: 24292045Posterior reversible leukoencephalopathy syndrome (PRES) is a recently described d...
Tacrolimus is an immunosuppressive drug mainly used to lower the risk of transplant rejection in i...
Reversible Posterior Encephalopathy Syndrome (PRES) is characterized by confusion, drowsiness, vomit...
Posterior reversible encephalopathy syndrome (PRES), also known as reversible posterior leukoencepha...
Posterior reversible encephalopathy syndrome (PRES) is a variable etiology clinical syndrome with si...
Posterior reversible encephalopathy syndrome (PRES), is a group of disorders which may present with ...
PRES is a neuroclinical and radiological syndrome that results from treatment with calcineurin inhib...
Posterior reversible encephalopathy syndrome (PRES) is a clinical neuroradiologic entity that is bec...
Since solid organ and hematopoietic stem cell transplantations have been performed increasingly rece...
Posterior reversible encephalopathy syndrome (PRES) is a clinico-neuroradiologic disease entity repr...
Tacrolimus is an immunosuppressive drug used to lower the risk of transplant rejection in individual...
Posterior reversible encephalopathy syndrome (PRES) is known to occur after solid organ transplantat...
<div><p>ABSTRACT Introduction: Posterior reversible leukoencephalopathy syndrome (PRES) was first d...
BACKGROUND AND PURPOSE: Posterior reversible encephalopathy syndrome (PRES) is known to occur after ...
BACKGROUND AND PURPOSE: Posterior reversible encephalopathy syndrome (PRES) is known to occur after ...
PubMedID: 24292045Posterior reversible leukoencephalopathy syndrome (PRES) is a recently described d...
Tacrolimus is an immunosuppressive drug mainly used to lower the risk of transplant rejection in i...
Reversible Posterior Encephalopathy Syndrome (PRES) is characterized by confusion, drowsiness, vomit...
Posterior reversible encephalopathy syndrome (PRES), also known as reversible posterior leukoencepha...
Posterior reversible encephalopathy syndrome (PRES) is a variable etiology clinical syndrome with si...